Reaction Details |
| Report a problem with these data |
Target | Aurora kinase B |
---|
Ligand | BDBM50535092 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1929868 (CHEMBL4433044) |
---|
IC50 | 79±n/a nM |
---|
Citation | Garton, NS; Barker, MD; Davis, RP; Douault, C; Hooper-Greenhill, E; Jones, E; Lewis, HD; Liddle, J; Lugo, D; McCleary, S; Preston, AGS; Ramirez-Molina, C; Neu, M; Shipley, TJ; Somers, DO; Watson, RJ; Wilson, DM Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors. Bioorg Med Chem Lett26:4606-4612 (2016) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Aurora kinase B |
---|
Name: | Aurora kinase B |
Synonyms: | AIK2 | AIM-1 | AIM1 | AIRK2 | ARK2 | AURKB | AURKB_HUMAN | Aurora B kinase (aurB) | Aurora B-INCENP | Aurora kinase 2 | Aurora kinase B (AURKB) | Aurora-related kinase 2 | STK-1 | STK1 | STK12 | STK5 | Serine/threonine-protein kinase aurora B |
Type: | Protein |
Mol. Mass.: | 39327.72 |
Organism: | Homo sapiens (Human) |
Description: | Q96GD4 |
Residue: | 344 |
Sequence: | MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMEN
SSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH
QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI
MEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYL
PPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPMGA
QDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA
|
|
|
BDBM50535092 |
---|
n/a |
---|
Name | BDBM50535092 |
Synonyms: | CHEMBL4469541 |
Type | Small organic molecule |
Emp. Form. | C17H19N7O |
Mol. Mass. | 337.3791 |
SMILES | CN(C)c1ccc(cn1)-c1cc2nccnc2c(NCCC(N)=O)n1 |
Structure |
|